SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-07-003344
Filing Date
2007-08-27
Accepted
2007-08-27 17:20:42
Documents
8
Period of Report
2007-05-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT FOR THE FISCAL YEAR ENDED: MAY 31, 2007 form20f.htm 20-F 764021
2 AMENDMENT TO EMPLOYMENT AGREEMENT exhibit4-23.htm EX-4.23 5996
3 AMENDED LICENSE AGREEMENT exhibit4-24.htm EX-4.24 75234
4 CEO CERTIFICATION exhibit12-1.htm EX-12.1 6019
5 CFO CERTIFICATION exhibit12-2.htm EX-12.2 6003
6 CEO AND CFO CERTIFICATION exhibit13-1.htm EX-13.1 3710
7 form20fx25x1.jpg GRAPHIC 17736
8 form20fx107x1.jpg GRAPHIC 1820
  Complete submission text file 0001062993-07-003344.txt   889574
Mailing Address SUITE 4 1200 WAVERLY STREET WINNIPEG A2 R3T 0P4
Business Address SUITE 4 1200 WAVERLY STREET WINNIPEG A2 R3T 0P4 204-487-7412
MEDICURE INC (Filer) CIK: 0001133519 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 20-F | Act: 34 | File No.: 001-31995 | Film No.: 071081478
SIC: 2834 Pharmaceutical Preparations